Reporter brief
Targeting Cellular Senescence With Fisetin for Improving Vascular Endothelial Function in Older Adults
What happened
Trial registry update: NOT_YET_RECRUITING. No results reported in the supplied registry record.
Why it matters
Assessment pending; this report does not establish a change in evidence.
What it does NOT prove
- No data are provided on study outcomes or findings, making it impossible to assess whether fisetin affected endothelial function or cellular senescence markers.
- The mechanism linking any effects of fisetin to senescence reduction versus other pathways cannot be determined from this abstract.
- Safety and tolerability outcomes are not reported.
Study design and sample
Rct; Human.
Older adults
- Design
- Rct
- Sample
- —
- Journal
- University of Colorado, Boulder
- Published
- Oct 13, 2026
Effect size
Not recorded.
Caveats
- Assessment: Unassessed.
- Only the source material recorded on this evidence page was assessed.
Conflicts and funding
Not recorded.
Previous evidence
See the Senolytics timeline and recorded assessment for prior evidence.
Primary source
Cancel Death charts and briefs may be reproduced editorially with attribution to CancelDeath.com. This brief is generated from the primary recorded source facts and assessment. Its review status is shown below; verify quotations against the paper before publication.